Skip to main content
Clinical Trials/NL-OMON23091
NL-OMON23091
Completed
Not Applicable

A phase II randomized multicenter study on efficacy and safety of cultured autologous skin (Tiscover®) and acellular dermal matrix (AS210) in chronic (arterio-)venous ulcers.

Free University medical center (VUmc)0 sites49 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
chronic (arterio) venous leg ulcers
Sponsor
Free University medical center (VUmc)
Enrollment
49
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

Wound healing in venous ulcers; mechanisms, approach and modern developments. Gibbs S, van den Hoogenband HM, de Boer EM. Ned Tijdschr Geneeskd. 2007 Mar 17;151(11):635-40. Review. Dutch. Autologous full-thickness skin substitute for healing chronic wounds.Gibbs S, van den Hoogenband HM, Kirtschig G, Richters CD, Spiekstra SW, Breetveld M, Scheper RJ, de Boer EM. Br J Dermatol. 2006 Aug;155(2):267-74.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
Free University medical center (VUmc)

Eligibility Criteria

Inclusion Criteria

  • 1\. Presence of confirmed venous, arterio\-venous ulcer;
  • 2\. Patients age over 18 years and under age of 90 years;

Exclusion Criteria

  • 1\. Ulcer chronicity \< 12 weeks;
  • 2\. \>15% increase of ulcer size in 4 weeks prior to inclusion or confirmed by historical data (patient status);

Outcomes

Primary Outcomes

Not specified

Similar Trials